Smith Julie

Stoke Therapeutics, Inc. · Director

Smith Julie is listed in public filings as director. This Smith Julie insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Stoke Therapeutics, Inc. (STOK), and Exelixis Inc (EXEL). Investors use Smith Julie's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Trades

CompanyValueActionPriceCurrent Price
Exelixis IncEXEL$887k20k sharesSellFeb 18, 2026$44.30--
Exelixis IncEXEL$2.0M44.1k sharesSellFeb 18, 2026$44.50--
Smith Julie | 交易笔记